Nectar Lifesciences
Latest round
- Seed
Last raised
- Mar 2022
Total raised
- $8M
Investors
- 2
About Nectar Lifesciences
Based in the US, and founded in 2021, Nectar Lifesciences offers a comprehensive, vertically integrated allergy healthcare platform by leveraging data and clinical research. The company uses data and clinical research to offer a personalized approach to allergy care. The company plans to use the seed funds to continue developing proprietary and personalized allergy solutions ahead of the nationwide launch of Nectar in the coming months.
Who invested in Nectar Lifesciences
2 investors across 1 round
See all investors in Nectar Lifesciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 17, 2022
Amount
$8M
Investors
Questions about Nectar Lifesciences
Who invested in Nectar Lifesciences?
Nectar Lifesciences has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nectar Lifesciences raised?
Nectar Lifesciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nectar Lifesciences last raise money?
Nectar Lifesciences's most recent round on record is a Seed, in Mar 2022.
What does Nectar Lifesciences do?
Based in the US, and founded in 2021, Nectar Lifesciences offers a comprehensive, vertically integrated allergy healthcare platform by leveraging data and clinical research.
Where is Nectar Lifesciences headquartered?
Nectar Lifesciences is headquartered in US.
Which VCs invest in companies like Nectar Lifesciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Nectar Lifesciences's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Nectar Lifesciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.